2107 Safety and Antitumor Activity Study Evaluating Loncastuximab Tesirine and Rituximab Versus Immunochemotherapy in Diffuse Large B-Cell Lymphoma

Research output: Contribution to conferencePresentation

Original languageAmerican English
StatePublished - Dec 6 2020

Cite this